Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system
- PMID: 18586085
- PMCID: PMC2760287
- DOI: 10.1016/j.bbadis.2008.06.001
Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system
Abstract
Growth hormone plays an important role in regulating numerous functions in vertebrates. Several pathways that negatively regulate the magnitude and duration of its signaling (including expression of tyrosine phosphatases, SOCS and PIAS proteins) are shared between signaling induced by growth hormone itself and by other cytokines. Here we overview downregulation of the growth hormone receptor as the most specific and potent mechanism of restricting cellular responses to growth hormone and analyze the role of several proteolytic systems and, specifically, ubiquitin-dependent pathways in this regulation.
Figures




Similar articles
-
The ubiquitin-proteasome pathway and the regulation of growth hormone receptor availability.Mol Cell Endocrinol. 2002 Nov 29;197(1-2):143-51. doi: 10.1016/s0303-7207(02)00258-7. Mol Cell Endocrinol. 2002. PMID: 12431807 Review.
-
The ubiquitin-proteasome pathway regulates lysosomal degradation of the growth hormone receptor and its ligand.Biochem Soc Trans. 2001 Aug;29(Pt 4):488-93. doi: 10.1042/bst0290488. Biochem Soc Trans. 2001. PMID: 11498015
-
The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels.PLoS One. 2011;6(9):e25358. doi: 10.1371/journal.pone.0025358. Epub 2011 Sep 29. PLoS One. 2011. PMID: 21980433 Free PMC article.
-
Investigation of the role of β-TrCP in growth hormone transduction defect (GHTD).Horm Mol Biol Clin Investig. 2020 Mar 2;41(2). doi: 10.1515/hmbci-2019-0029. Horm Mol Biol Clin Investig. 2020. PMID: 32114520
-
Emerging roles of the ubiquitin-proteasome system in the steroid receptor signaling.Arch Pharm Res. 2012 Mar;35(3):397-407. doi: 10.1007/s12272-012-0301-x. Epub 2012 Apr 5. Arch Pharm Res. 2012. PMID: 22477185 Review.
Cited by
-
Signaling cross talk between growth hormone (GH) and insulin-like growth factor-I (IGF-I) in pancreatic islet β-cells.Mol Endocrinol. 2011 Dec;25(12):2119-33. doi: 10.1210/me.2011-1052. Epub 2011 Oct 27. Mol Endocrinol. 2011. PMID: 22034225 Free PMC article.
-
Growth hormone - past, present and future.Nat Rev Endocrinol. 2018 May;14(5):285-300. doi: 10.1038/nrendo.2018.22. Epub 2018 Mar 16. Nat Rev Endocrinol. 2018. PMID: 29546874 Review.
-
TIMP3 Modulates GHR Abundance and GH Sensitivity.Mol Endocrinol. 2016 Jun;30(6):587-99. doi: 10.1210/me.2015-1302. Epub 2016 Apr 13. Mol Endocrinol. 2016. PMID: 27075707 Free PMC article.
-
Classical and novel GH receptor signaling pathways.Mol Cell Endocrinol. 2020 Dec 1;518:110999. doi: 10.1016/j.mce.2020.110999. Epub 2020 Aug 22. Mol Cell Endocrinol. 2020. PMID: 32835785 Free PMC article. Review.
-
Eliminative signaling by Janus kinases: role in the downregulation of associated receptors.J Cell Biochem. 2014 Jan;115(1):8-16. doi: 10.1002/jcb.24647. J Cell Biochem. 2014. PMID: 23959845 Free PMC article. Review.
References
-
- Isaksson OG, Eden S, Jansson JO. Mode of action of pituitary growth hormone on target cells. Annu Rev Physiol. 1985;47:483–499. - PubMed
-
- Bartke A. Minireview: role of the growth hormone/insulin-like growth factor system in mammalian aging. Endocrinology. 2005;146:3718–3723. - PubMed
-
- Melmed S. Medical progress: Acromegaly. N Engl J Med. 2006;355:2558–2573. - PubMed
-
- Vance ML, Mauras N. Growth hormone therapy in adults and children. N Engl J Med. 1999;341:1206–1216. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources